BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26384308)

  • 1. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
    Lee M; Beggs SM; Gildea D; Bupp S; Lichtenberg J; Trivedi NS; ; Hu Y; Bodine DM; Crawford NP
    Oncotarget; 2015 Oct; 6(31):31557-68. PubMed ID: 26384308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer.
    De Faveri LE; Hurst CD; Platt FM; Taylor CF; Roulson JA; Sanchez-Carbayo M; Knowles MA; Chapman EJ
    Br J Cancer; 2013 Apr; 108(6):1368-77. PubMed ID: 23549060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
    Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
    Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
    Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
    Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis.
    Kurita M; Kuwajima T; Nishimura I; Yoshikawa K
    J Neurosci; 2006 Nov; 26(46):12003-13. PubMed ID: 17108174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
    Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
    Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.
    Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC
    Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necdin: a multi functional protein with potential tumor suppressor role?
    Chapman EJ; Knowles MA
    Mol Carcinog; 2009 Nov; 48(11):975-81. PubMed ID: 19626646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Role of Huntingtin in Breast Cancer Metastasis.
    Thion MS; McGuire JR; Sousa CM; Fuhrmann L; Fitamant J; Leboucher S; Vacher S; du Montcel ST; Bièche I; Bernet A; Mehlen P; Vincent-Salomon A; Humbert S
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26293574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.